SS Innovations International Files 8-K

Ticker: SSII · Form: 8-K · Filed: Oct 14, 2025 · CIK: 1676163

Sentiment: neutral

Topics: 8-K, regulatory-disclosure, financial-reporting

TL;DR

SS Innovations International filed an 8-K on Oct 14, 2025, covering Reg FD and financials. Formerly AVRA Medical Robotics.

AI Summary

SS Innovations International, Inc. filed an 8-K on October 14, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as AVRA Medical Robotics, Inc. until June 1, 2016, is incorporated in Florida and has its principal executive offices in Gurugram, Haryana, India.

Why It Matters

This filing provides an update on the company's regulatory disclosures and financial reporting, which is important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing for an 8-K, indicating standard corporate reporting rather than a specific event that would inherently increase risk.

Key Numbers

Key Players & Entities

FAQ

What specific items are being disclosed under Regulation FD?

The filing indicates 'Regulation FD Disclosure' as an item, but the specific details of the disclosure are not provided in this header information.

What financial statements or exhibits are included with this 8-K?

The filing lists 'Financial Statements and Exhibits' as an item, but the content of these statements and exhibits is not detailed in the provided text.

What is the primary business of SS Innovations International, Inc.?

The Standard Industrial Classification (SIC) code provided is 3841, which corresponds to 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS'.

Where are the principal executive offices of SS Innovations International, Inc. located?

The principal executive offices are located at 05, 3rd Floor, iLabs Info Technology Centre, Udyog Vihar, Phase III, Gurugram, Haryana, India.

When did the company change its name from AVRA Medical Robotics, Inc.?

The company changed its name from AVRA Medical Robotics, Inc. on June 1, 2016.

Filing Stats: 880 words · 4 min read · ~3 pages · Grade level 12.5 · Accepted 2025-10-14 06:07:48

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. Attached hereto is an updated October 2025 Company Presentation (the " Presentation "), which SSi intends to use in communications to shareholders and the investment community. A copy of the Presentation is included with this Report as Exhibit 99.1 . The information set forth in this Item 7.01 and in the Presentation included with this Report as Exhibit 99.1 , are deemed to be "furnished" and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that Section. The information set forth in this Item 7.01 and in the Presentation included with this Report as Exhibit 99.1 , including without limitation, information accessed through the link set forth above, shall not be deemed incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in such filing.

Forward-Looking Statements

Forward-Looking Statements This Report may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipate," "assume," "believe," "estimate," "expect," "will," "intend," "may," "plan," "project," "should," "could," "seek," "designed," "potential," "forecast," "target," "objective," "goal," or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SSi's future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and uncertainties, although not all risks and uncertainties, that could cause the Company's actual results to differ materially from those presented in its forward-looking statements are set forth in the Company's Annual Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission, as such risks, uncertainties and other important factors may be updated from time to time in the Company's subsequent reports. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to SSi's operations, results of operations, growth strategy and liquidity.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* October 2025 Company Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Furnished but not filed. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 14, 2025 SS INNOVATIONS INTERNATIONAL, INC. By: /s/ Sudhir Srivastava Sudhir Srivastava, M.D. Chairman and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing